Ocular Therapeutix
OCUL
#5255
Rank
โ‚น162.49 B
Marketcap
โ‚น739.91
Share price
1.86%
Change (1 day)
-30.09%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -โ‚น27.74 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are โ‚น52.05 Million. In 2025 the company made an earning of -โ‚น25.73 Billion a decrease over its 2024 earnings that were of -โ‚น18.72 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น27.74 Billion7.81%
2025 -โ‚น25.73 Billion37.43%
2024 -โ‚น18.72 Billion139.68%
2023 -โ‚น7.81 Billion13.65%
2022 -โ‚น6.88 Billion984.05%
2021 -โ‚น0.64 Billion-95.79%
2020 -โ‚น15.06 Billion80.19%
2019 -โ‚น8.36 Billion44.01%
2018 -โ‚น5.81 Billion-5.38%
2017 -โ‚น6.14 Billion41.79%
2016 -โ‚น4.33 Billion12.47%
2015 -โ‚น3.85 Billion38.75%
2014 -โ‚น2.78 Billion115.12%
2013 -โ‚น1.29 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-โ‚น1.09 Billion-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-โ‚น0.5 Billion-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-โ‚น15.61 Billion-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚น15.50 B-153.18%๐Ÿ‡บ๐Ÿ‡ธ USA